A lipid-soluble red ginseng extract inhibits the growth of human lung tumor xenografts in nude mice

Journal of Medicinal Food

Volumn 13, Issue 1, 2010, Pages 1-5

  Lee, Sung Dong ^a   Park, Song Kyu ^b   Lee, Eun Sil ^c   Kim, Hwan Mook ^b   Lee, Chang Woo ^b   Lee, Kiho ^b   Lee, Ki Hoon ^b   Kang, Moo Rim ^b   Lee, Kwang Seung ^c   Lee, Junsoo ^c   Hwang, Woo Ik ^a   Kim, Dong Chung ^d,e  

^a Korea University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Chungbuk National University   (South Korea)

^d Sungkyunkwan University   (South Korea)

^e Chungwoon University   (South Korea)

Author keywords

Anticancer effect; Human tumor xenograft; Lipid soluble ginseng extract; Oral administration

Indexed keywords

DOXORUBICIN; GINSENG EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER INHIBITION; CANCER PREVENTION; CARCINOMA CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; FEMALE; GINSENG; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LIPID SOLUBILITY; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPIDS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; SOLUBILITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS; PANAX GINSENG;

EID: 76649096690     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.1142     Document Type: Article

References (31)

1. Attele AS, Wu JA, Yuan CS: Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58: 1685-1693.
2. Kim YS, Kang KS, Kim SI: Study on antitumor and immunomodulating activities of polysaccharide fractions from Panax ginseng: comparison of effects of neutral and acidic polysaccharide fraction. Arch Pharm Res 1990;13:330-337.
3. Park EK, Choo MK, Han MJ, Kim DH: Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 2004;133:113-120.
4. Liu M, Lin L, Song B, Wang L, Zhang C, Zhao J, Liu J: Cranberry phytochemical extract inhibits SGC-7901 cell growth and human tumor xenografts in Balb=c nu=nu mice. J Agric Food Chem 2009;57:762-768.
5. Helms S: Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259-274.
6. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND: Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999;14:869-875.
7. King ML, Adler SR, Murphy LL: Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation. Integr Cancer Ther 2006;5:236-243.
8. Yun TK, Kim SH, Lee YS: Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. Anticancer Res 1995;15:839-845.
9. Fukushima S, Wanibuchi H, Li W: Inhibition by ginseng of colon carcinogenesis in rats. J Korean Med Sci 2001;16 Suppl:S75-S80.
10. Panwar M, Samarth R, Kumar M, Yoon WJ, Kumar A: Inhibition of benzo(a)pyrene induced lung adenoma by Panax ginseng extract, EFLA400, in Swiss albino mice. Biol Pharm Bull 2005; 28:2063-2067.
11. Nakada H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, Kudoh K, Nakata I, Shinomiya N: Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 1998;89:733-740.
12. Wang Z, Zheng Q, Liu K, Zheng R: Ginsenoside Rh2 enhances antitumor activity and decreases genotoxic effect of cyclophosphamide. Basic Clin Pharmacol Toxicol 2006;98:411-415.
13. Cui Y, Shu X, Gao Y, Cai H, Tao M, Zheng W: Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol 2006;163:645-653.
14. Suh SO, Kroh M, Kim NR, Joh YG, Cho MY: Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer. Am J Clin Med 2002;30:483-494.
15. Matsunaga H, Katano M, Yamamoto H, Fujito H, Mori M, Takata K: Cytotoxic activity of polyacetylene compounds in Panax ginseng C. A. Meyer. Chem Pharm Bull 1990;38:3480-3482.
16. Hwang WI: A study on the antitumor activity of Panax ginseng. Korean J Ginseng Sci 1993;17:52-60.
17. Kim JY, Lee KW, Kim SH, Wee JJ, Kim YS, Lee HJ: Inhibitory effect of tumor cell proliferation and induction of G2=M cell cycle arrest by panaxytriol. Planta Med 2002;68:119-122.
18. Park CE, Baek N, Park C: Extraction of panaxynol and panaxydol compounds from Korean ginseng. Biotechnol Bioprocess Eng 2001;6:433-437.
19. Kim HM, Kang JS, Lim J, Park S, Lee K, Yoon YD, Lee CW, Lee KH, Han G, Yang K, Kim YJ, Kim Y, Han S: Inhibition of human ovarian tumor growth by cytokine-induced killer cells. Arch Pharm Res 2007;30:1464-1470.
20. Adams RP: Identification of Essential Oil Component by Gas Chromatography=Quadrupole Mass Spectroscopy. Allured Publishing Corp., Carol Stream, IL, 2004.
21. Choi Y, Kim Y, Hong Y, Park SK, Yoo K: Temporal changes of lung cancer mortality in Korea. J Korean Med Sci 2007;22:524-528.
22. Singh RP, Tyagi AK, Dhanalakshmi S, Agarwal R, Agarwal C: Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. Int J Cancer 2004;108:733-740.
23. Kim DC, Lee JY, In M, Chae HJ, Hwang YK, Hwang WI: Effects of polyacetylenes in ginseng on activity of enzymes related to post-translational modification of ras protein and effects of petroleum ether extract of ginseng on progression of cell cycle. J Ginseng Res 2001;25:156-161.
24. Pyo JS, Ju HK, Park JH, Kwon SW: Determination of volatile biomarkers for apoptosis and necrosis by solid-phase microextraction- gas chromatography=mass spectrometry: a pharmacometabolomic approach to cisplatin's cytotoxicity to human lung cancer cell lines. J Chromatogr B 2008;876:170-174.
25. Youn M, Kim J, Park S, Kim Y, Park C, Kim ES, Park K, So HS, Park R: Potential anticancer properties of the water extract of Inontus obliquus by induction of apoptosis in melanoma B16- F10 cells. J Ethnopharmacol 2009;121:221-228.
26. Fukuda S, Ikeda M, Nakamura M, Yan X, Xie Y: Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium. Radiat Prot Dosim 2009;133:12-19.
27. Yoo G, Lee SD, In M, Hwang WI, Lee KS, Lee ES, Kim DC, Chae HJ: An alternative sequential extraction process for maximal utilization of bioactive components from Korean red ginseng. Korean J Chem Eng 2009;26:1094-1097.
28. Washida D, Kitanaka S: Determination of polyacetylenes and ginsenosides in Panax species using high performance liquid chromatography. Chem Pharm Bull 2003;51:1314-1317.
29. Zheng G, Lu W, Aisa HA, Cai J: Absolute configuration of falcarinol, a potent antitumor agent commonly occurring in plants. Tetrahedron Lett 1999;40:2181-2182.
30. Kim J, Moon G, Kim H, Lee Y: Antioxidant properties of ginseng (P. ginseng C.A. Meyer) extracts by organic solvent fractionation. J Food Sci Nutr 2007;12:267-272.
31. Ajith TA, Usha S, Nivitha V: Ascorbic acid and a-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 2007;375:82-86